Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Provectus Biopharmaceuticals Inc (OTCQB:PVCT)

0.0335
Delayed Data
As of Oct 19
 -0.0067 / -16.79%
Today’s Change
0.01
Today|||52-Week Range
0.08
+70.66%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$12.4M

Company Description

Provectus Biopharmaceuticals, Inc. is a development stage biopharmaceutical company, which engages in the development of ethical pharmaceuticals for oncology and dermatology indications. Its prescription drugs treats several life threatening cancers including metastatic melanoma, liver cancer, and breast cancer. The company was founded by Eric A. Wachter on January 17, 2002 and is headquartered in Knoxville, TN.

Contact Information

Provectus Biopharmaceuticals, Inc.
10025 Investment Drive
Knoxville Tennessee 37932
P:(866) 594-5999
Investor Relations:

Employees

Shareholders

Individual stakeholders4.22%
Mutual fund holders--
Other institutional--

Top Executives

Timothy C. ScottPresident & Chief Executive Officer
John R. GlassChief Financial Officer
Eric A. WachterChief Technology Officer & Director